Buy, hold, sell: BHP, CSL, and Woodside shares

Let's see if analysts are bullish or bearish on these giants.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

There are a lot of blue-chip ASX 200 shares to pick from on the Australian share market.

But not all are necessarily buys right now.

So, to narrow things down, let's see what analysts are saying about three of the most popular shares on the ASX 200 index. Here's what you need to know:

A man casually dressed looks to the side in a pensive, thoughtful manner with one hand under his chin, and holding a mobile phone in his other hand.

Image source: Getty Images

BHP Group Ltd (ASX: BHP)

BHP is the world's largest mining company and a major producer of commodities such as iron ore, copper, and metallurgical coal.

One positive currently working in its favour is the strength in copper prices. Copper is widely viewed as one of the most important commodities for electrification, renewable energy infrastructure, and electric vehicles. With demand expected to rise strongly over the coming decade, BHP's significant exposure to copper could become an increasingly valuable part of its portfolio.

But does this make BHP shares a buy?

Morgan Stanley has an overweight rating on the mining giant with a $56.00 price target. Meanwhile, Ord Minnett has an accumulate rating with a $54.00 price target. This compares favourably to the current BHP share price of $49.39.

CSL Ltd (ASX: CSL)

CSL is one of Australia's largest healthcare companies and a global leader in plasma therapies, vaccines, and biotechnology products.

Unlike some other ASX heavyweights, CSL has not enjoyed much positive momentum recently. Its shares have come under significant pressure and are trading well below their historical highs, which has left the company looking relatively cheap compared to its long-term valuation.

Is this an opportunity to buy a high-quality healthcare business with global operations, a large research pipeline, and strong positions in specialised treatment markets?

Despite its struggles, brokers remain positive on CSL and see value in its shares. Morgans has a buy rating on the healthcare giant with a $241.34 price target, while UBS also has a buy rating and a $235.00 price target. This compares to the current CSL share price of $139.86.

Woodside Energy Group Ltd (ASX: WDS)

Woodside is Australia's largest oil and gas producer and generates the bulk of its earnings from global energy markets.

One of the major positives currently supporting the company is the strength in oil prices, which are trading above US$100 per barrel due to the war in the Middle East. Higher oil prices typically translate into stronger cash flow for energy producers, which can support dividends and investment in new projects.

Does this make Woodside shares a buy?

Well, due to recent share price strength, brokers are largely on the fence with this one. UBS currently has a neutral (hold) rating on the company with a $28.10 price target, while Macquarie also has a neutral rating with a $30.00 price target. This compares to the current Woodside share price of $31.51.

Motley Fool contributor James Mickleboro has positions in CSL and Woodside Energy Group Ltd. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended CSL and Macquarie Group. The Motley Fool Australia has positions in and has recommended Macquarie Group. The Motley Fool Australia has recommended BHP Group and CSL. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

A happy male investor turns around on his chair to look at a friend while a laptop runs on his desk showing share price movements
Broker Notes

Buy, hold, sell: Newmont, Rio Tinto, and Santos shares

Morgans has updated its view on these mining shares.

Read more »

Male investor holds a magnifying glass to his eye.
Broker Notes

Brokers name 3 ASX shares to buy in August

Three broker buy ratings worth a closer look this month.

Read more »

A grey-haired mature-aged man with glasses stands in front of a blackboard filled with mathematical workings as he holds a pad of paper in one hand and a pen in the other and stands smiling at the camera.
Broker Notes

5 ASX shares attracting upgraded ratings this week

Brokers have new confidence in Westpac, Mineral Resources, Whitehaven Coal, and others this week.

Read more »

Machinery at a mine site.
Broker Notes

3 ASX mining companies this broker says could more than double in value

There's plenty of potential in these companies.

Read more »

Miner standing in front of trucks and smiling, symbolising a rising share price.
Broker Notes

3 ASX mining companies that could return better than 50% according to Macquarie

These three stocks could deliver plenty of upside.

Read more »

Female miner standing smiling in a mine.
Resources Shares

4 ASX 200 mining shares to buy following quarterly updates

Mining shares outperformed in FY26 as the new mining boom in Australia continued.

Read more »

Green keyboard button saying buy stock.
Broker Notes

8 ASX 200 shares with strengthened buy ratings this week

Brokers retained a positive view on NAB, Liontown, Mineral Resources, and other shares this week. 

Read more »

A group of people clink wine glasses in an outdoor, late afternoon setting to celebrate the rising Treasury Wine share price
Broker Notes

Buy, hold, sell: Saluda Medical, Tasmea, Treasury Wine Estates shares

We review new ratings on these All Ords stocks from expert market analysts. 

Read more »